Sanofi, Carlyle to buy Elder Pharma for $450 mn

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 25 Jul, 2013

Singapore: Sanofi's India unit and Carlyle group are in talks to buy the domestic drug formulation business of Indian dr...Read more

Gilead's cancer drug under FDA scrutiny

Generics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 15 Mar, 2016

Singapore: US Food and Drug Administration has raised alarm for Gilead Science's cancer medicine Zydelig (idelalisib) du...Read more

US FDA seeks inputs on its generic drug amendments

Generics |  Regulatory | By BioSpectrum Bureau  | 4 Comment | 04 Sep, 2012

Singapore: On July 9, 2012, the Generic Drug User Fee Amendments of 2012 (GDUFA) was enacted by the US. The Food and Dru...Read more

Lupin gets FDA nod for generic Ortho Tri-cyclen Lo Tablets

Generics |  Regulatory | By BioSpectrum Bureau  | 4 Comment | 05 Jul, 2012

Mumbai: Mumbai-based pharma major Lupin's subsidiary, Lupin Pharmaceuticals, has received approval for its Norgestimate ...Read more

FDA approves Sun Pharma's generic Prandin

Generics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 12 Jul, 2013

Singapore: The US Food and Drug Administration (FDA) has given its finally approval to India's Sun Pharmaceutical Indust...Read more

Cipla, Alembic contest Indian drug pricing in court

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 17 Jul, 2013

Singapore: Miffed at Indian government's move to slash prices of essential medicines through the new drug pricing policy...Read more

Indian drug dealers worried about $1.69 bn old stocks

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 02 Aug, 2013

New Delhi: Ahead of the Drug Price Control Order (DPCO) to revise drug prices that came into effect on July 29, medicine...Read more

First generic versions of Cymbalta receive FDA nod

Generics |  Regulatory | By BioSpectrum Bureau  | 4 Comment | 13 Dec, 2013

Singapore: US Food and Drug Administration has approved the first generic versions of Cymbalta (duloxetine delayed-relea...Read more

Takeda close to releasing Norovirus vaccine

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 08 Jul, 2013

Singapore: Japan's drug major Takeda Pharmaceutical has said that they are set to finish the early stage human studies o...Read more

Daiichi Sankyo's subsidiary launches four new generic drugs

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 18 Jun, 2015

Daiichi Sankyo Company Limited has announced that on Friday, June 19, its generics subsidiary, Daiichi Sankyo Espha, wil...Read more

US FDA extends timeline for generic drug approval

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 29 Oct, 2012

Singapore: In a recent move, the US Food and Drug Administration (FDA) has decided to extend the timeline for granting t...Read more

FDA approves generic versions of Plavix

Generics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 18 May, 2012

Singapore: The US Food and Drug Administration has approved generic versions of the blood thinning drug Plavix (clopidog...Read more

FDA finds hair from human arm in Ranbaxy drugs

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 19 Sep, 2013

Singapore: The US FDA released a set of further current good manufacturing practices (cGMP) violations that have been no...Read more

TWi Pharma launches generic version of appetite loss drug

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 29 Jul, 2015

Singapore: Taiwan based TWi Pharmaceuticals, has launched generic version of Par Pharmaceutical's Megace ES (megestrol a...Read more

Trans-Pacific trade talks reach stalemate over IP rights

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 23 Jul, 2013

Singapore: What started as an effort to lower trade barriers across 12 Pacific Rim nations, from the US and Canada to Vi...Read more

Activists challenge Gilead to give up Hep C drug patent

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 21 May, 2015

Singapore: Initiative for Medicines, Access & Knowledge (I-MAK), a team of lawyers and scientists campaigning for gl...Read more

Teva, Sun to pay $2.15 bn to Pfizer, Takeda to settle patent suit

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 13 Jun, 2013

Singapore: Teva Pharmaceuticals Industries, Israel, and Sun Pharmaceutical Industries, India, are going to pay a combine...Read more

Daiichi Sankyo collaborates with Maruishi Pharmaceutical

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 23 Jun, 2015

Japan's Daiichi Sankyo Company and Maruishi Pharmaceutical Co. Ltd have signed an agreement to collaborate on the commer...Read more